Blessie Elizabeth Nelson (Blessie Nelson)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Metastatic Colorectal Cancer

Top Venues

NPJ precision oncology

Molecular cancer therapeutics

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Blessie Elizabeth Nelson, Vivek Subbiah
Predicting the Abscopal Phenomenon-Reply. Molecular cancer therapeutics 23 (2) (2024)
Blessie Elizabeth Nelson, Vivek Subbiah
Predicting the Abscopal Phenomenon-Reply. Molecular cancer therapeutics 23 (2) (2024)
Blessie Elizabeth Nelson, Sadia Saleem, Senthil Damodaran, Neeta Somaiah, Sarina Piha-Paul, Julia Ann Moore, Bulent Yilmaz, Deby Ogbonna, Daniel D Karp, Ecaterina Ileana Dumbrava, Apostolia-Maria Tsimberidou, David S Hong, Jordi Rodon Ahnert, Denái R Milton, Xiaofeng Zheng, Daniel J Booser, Nuhad K Ibrahim, Anthony P Conley, Priya Bhosale, Cristhiam M Rojas Hernandez, Debasish Tripathy, Aung Naing, Funda Meric-Bernstam
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer. Cancer (2023)
Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, Siqing Fu, Vivek Subbiah, Anil K Sood, Jordi Rodon, Daniel D Karp, George Blumenschein, Edmund S Kopetz, Shubham Pant, Sarina A Piha-Paul
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors. The oncologist (2023)
Mohamed A Gouda, Blessie Elizabeth Nelson, Lars Buschhorn, Adam Wahida, Vivek Subbiah
Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical implications. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Blessie Elizabeth Nelson, Jacob J Adashek, Aakash Akshay Sheth, Vivek Subbiah
Predicting the Abscopal Effect: Associated Tumor Histologic Subtypes and Biomarkers. Molecular cancer therapeutics 22 (6) (2023)
Blessie Elizabeth Nelson, Neha K Reddy, Jason T Huse, Behrang Amini, Mirella Nardo, Mohamed A Gouda, Shiao-Pei Weathers, Vivek Subbiah
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma. NPJ precision oncology 7 (1) (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Blessie Elizabeth Nelson, Jason Roszik, Filip Janku, David S Hong, Shumei Kato, Aung Naing, Sarina Piha-Paul, Siqing Fu, Apostolia-Maria Tsimberidou, Maria Cabanillas, Naifa Lamki Busaidy, Milind Javle, Lauren Averett Byers, John Victor Heymach, Funda Meric-Bernstam, Vivek Subbiah
BRAF v600E-mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study. NPJ precision oncology 7 (1) (2023)
Blessie Elizabeth Nelson, Chinenye Lynette Ejezie, Bettzy A Stephen, Mirella Nardo, Erick Campbell, Jing Gong, David S Hong, Siqing Fu, Timothy A Yap, Mariela Blum Murphy, Sarina Piha-Paul, Naval G Daver, Cristhiam M Rojas-Hernandez, Aung Naing
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience. Journal of hematology 11 (3) (2022)
Blessie Elizabeth Nelson, Jacob J Adashek, Steven H Lin, Vivek Subbiah
On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happenings. Cancer medicine (2022)
Blessie Elizabeth Nelson, Angelina Hong, Ike Okereke, Avi Markowitz, Maurice Willis, Palawinnage V Muthukumarana, Ranjana Nawgiri
Non-neoplastic inflammatory pseudotumor of the lung after immunotherapy for melanoma: A diagnostic pitfall on fine needle aspiration biopsy of lung. Diagnostic cytopathology 49 (10) (2021)
Blessie Elizabeth Nelson, Dylan Warfield, Camilo Velasquez Mejia, John Patrick Walker
Rare presentation of growing teratoma syndrome in patient with remote history of testicular cancer resection. Journal of surgical case reports 2021 (1) (2021)
Blessie Elizabeth Nelson, Angelina Hong, Fatima Iqbal, Bagi Jana
A unique case of hemolytic-uremic syndrome secondary to enteropathogenic E Coli. Clinical case reports 8 (12) (2020)